Latest filing published 19 Mar 2024 for LSL Pharma Group Inc..
No signal scores available.
This profile gathers the share dealings of Luc Mainville in LSL Pharma Group Inc. In total, 2 filings cover trades dated from 22 February 2023 to 18 March 2024.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The record was last updated on 19 March 2024 with a transaction in LSL Pharma Group Inc. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations